文献速递心脑血管急症重症综合管理与镇静镇痛

入院白细胞计数与ST段抬高型心肌梗死患者晚期心源性休克及30天全因死亡相关

Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction.
PubMed 文献 · Shock · 2020-01-01
一句话结论STEMI患者入院时中性粒细胞计数和中性粒细胞/淋巴细胞比值升高与离开导管室后发生晚期心源性休克及30天全因死亡独立相关,与早期心源性休克无关。

该研究纳入两家三级心脏中心一年内收治的1892例STEMI患者,按入院白细胞计数四分位分组,主要终点为导管室前(早期)和离开导管室后(晚期)发生心源性休克,次要终点为30天全因死亡。结果显示194例(10%)发生心源性休克,122例(6.4%)30天内死亡。中性粒细胞最高四分位组(OR 2.54,95%CI 1.40-4.60,P=0.002)和NLR最高四分位组(OR 3.64,95%CI 2.02-6.54,P<0.0001)发生晚期心源性休克风险增加,而早期心源性休克各四分位间无风险差异。两种生物标志物均与30天死亡率升高相关(plogrank<0.0001),中性粒细胞高水平独立关联30天死亡(HR 1.95,95%CI 1.25-3.03,P=0.003)。

要点

  • STEMI入院时中性粒细胞最高四分位组发生晚期心源性休克风险增加(OR 2.54,95%CI 1.40-4.60,P=0.002),早期心源性休克无差异。
  • NLR最高四分位组晚期心源性休克风险增加更明显(OR 3.64,95%CI 2.02-6.54,P<0.0001)。
  • 中性粒细胞高水平独立关联30天全因死亡(HR 1.95,95%CI 1.25-3.03,P=0.003)。
  • 中性粒细胞和NLR均与30天死亡率升高相关(plogrank<0.0001)。
  • 研究纳入1892例STEMI患者,10%发生心源性休克,6.4%在30天内死亡。

适用人群与场景

  • 两家三级心脏中心一年内收治的STEMI患者,共1892例。

研究设计与关键结果

  • 研究类型为在两家三级心脏中心开展的研究,纳入1892例STEMI患者,按入院白细胞计数四分位分组。
  • 主要终点:194例(10%)发生心源性休克;中性粒细胞最高四分位组晚期心源性休克风险增加(OR 2.54,95%CI 1.40-4.60,P=0.002),NLR最高四分位组晚期心源性休克风险增加(OR 3.64,95%CI 2.02-6.54,P<0.0001),早期心源性休克各四分位间无风险差异。
  • 次要终点:122例(6.4%)30天内死亡;中性粒细胞和NLR均与30天死亡率升高相关(plogrank<0.0001);中性粒细胞高水平独立关联30天全因死亡(HR 1.95,95%CI 1.25-3.03,P=0.003)。

证据类型、等级与局限

  • 证据类型:在两家三级心脏中心开展的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对STEMI患者,入院时中性粒细胞计数和NLR升高可能提示离开导管室后发生晚期心源性休克及30天死亡风险增加,作者认为二者独立关联晚期心源性休克和30天死亡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Thirty-day mortality in ST-elevation myocardial infarction (STEMI) patients is primarily driven by cardiogenic shock (CS). High neutrophil counts and high neutrophil/lymphocyte ratios (NLR) have previously been associated with mortality in STEMI patients; however, there is only sparse knowledge regarding their association with CS.

PURPOSE: We sought to assess the associations between neutrophil count and NLR with the development of CS as well as 30-day mortality in STEMI patients.

METHODS: Patients admitted with STEMI at two tertiary Heart Centres throughout 1 year were included in the study and stratified into quartiles according to the level of leukocyte count upon admission. The primary endpoint was development of CS both before (early CS) and after leaving the catheterization laboratory (late CS). The secondary endpoint was all-cause 30-day mortality.

RESULTS: A total of 1,892 STEMI patients were included, whereof 194 (10%) developed CS while 122 (6.4%) died within 30 days. Patients in the highest quartile of neutrophils (OR: 2.54; 95% CI: 1.40-4.60; P = 0.002) and NLR (OR: 3.64; 95% CI: 2.02-6.54; P<0.0001) were at increased risk of developing late CS compared with patients in the lower quartiles, whereas there was no risk difference across quartiles regarding development of early CS. Both biomarkers correlated strongly to an increased 30-day mortality (plogrank<0.0001) and, moreover, a high level of neutrophils was independently associated with 30-day mortality (HR: 1.95; 95% CI: 1.25-3.03; P = 0.003).

CONCLUSION: High levels of neutrophils and a high NLR upon admission for STEMI were independently associated with an increased risk of developing late CS and, additionally, both biomarkers showed association to 30-day mortality.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Klein A, Wiberg S, Hassager C, et al. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction. Shock. 2020. PMID: 31058719. doi:10.1097/SHK.0000000000001369

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。